相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。3D-QSAR and in-silico Studies of Natural Products and Related Derivatives as Monoamine Oxidase Inhibitors
Priyanka Dhiman et al.
CURRENT NEUROPHARMACOLOGY (2018)
Synthesis and evaluation of 7-substituted coumarin derivatives as multimodal monoamine oxidase-B and cholinesterase inhibitors for the treatment of Alzheimer's disease
Jacques Joubert et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Tranylcypromine in mind (Part I): Review of pharmacology
Sven Ulrich et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2017)
Use of monoamine oxidase inhibitors in chronic neurodegeneration
Peter Riederer et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2017)
Coumarin derivatives: an updated patent review (2015-2016)
Anastasia Detsi et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2017)
Coumarin versus Chromone Monoamine Oxidase B Inhibitors: Quo Vadis?
Andre Fonseca et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Sembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer's Diseases
Edilio Borroni et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Different iron deposition patterns in early- and middle-late-onset Parkinson's disease
Min Xuan et al.
PARKINSONISM & RELATED DISORDERS (2017)
Structural Exploration of Synthetic Chromones as Selective MAO-B Inhibitors: A Mini Review
Bijo Mathew et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2017)
Multitarget-Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H3R Antagonism for Neurodegenerative Diseases
Oscar M. Bautista-Aguilera et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Emerging role of monoamine oxidase as a therapeutic target for cardiovascular disease
Soni Deshwal et al.
CURRENT OPINION IN PHARMACOLOGY (2017)
Recent progress in repositioning Alzheimer's disease drugs based on a multitarget strategy
M. Amelia Santos et al.
FUTURE MEDICINAL CHEMISTRY (2016)
Kaempferol as Selective Human MAO-A Inhibitor: Analytical Detection in Calabrian Red Wines, Biological and Molecular Modeling Studies
Maria Concetta Gidaro et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2016)
Inhibition of Human Monoamine Oxidase: Biological and Molecular Modeling Studies on Selected Natural Flavonoids
Simone Carradori et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2016)
Aldehyde dehydrogenase (ALDH) in Alzheimer's and Parkinson's disease
Edna Gruenblatt et al.
JOURNAL OF NEURAL TRANSMISSION (2016)
Dual inhibition of survivin and MAOA synergistically impairs growth of PTEN-negative prostate cancer
S. Xu et al.
BRITISH JOURNAL OF CANCER (2015)
Multi-target tacrine-coumarin hybrids: Cholinesterase and monoamine oxidase B inhibition properties against Alzheimer's disease
Sai-Sai Xie et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
New Frontiers in Selective Human MAO-B Inhibitors
Simone Carradori et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Efficacy and safety of selegiline transdermal system (STS) for the atypical subtype of major depressive disorder: pooled analysis of 5 short-term, placebo-controlled trials
Chi-Un Pae et al.
CNS SPECTRUMS (2014)
New insights into the biological properties of Crocus sativus L.: chemical modifications, human monoamine oxidases inhibition and molecular modeling studies
Celeste De Monte et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Safinamide for the treatment of Parkinson's disease
Livia Dezsi et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2014)
Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis
Jason Boyang Wu et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Monoamine oxidases as sources of oxidants in the heart
Nina Kaludercic et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
Selective MAO-B inhibitors: a lesson from natural products
Simone Carradori et al.
MOLECULAR DIVERSITY (2014)
The role of iron in brain ageing and neurodegenerative disorders
Roberta Ward et al.
LANCET NEUROLOGY (2014)
Two-Year, Randomized, Controlled Study of Safinamide as Add-on to Levodopa in Mid to Late Parkinson's Disease
Rupam Borgohain et al.
MOVEMENT DISORDERS (2014)
Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: Focus on modulation of CNS monoamine neurotransmitter release
John P. M. Finberg
PHARMACOLOGY & THERAPEUTICS (2014)
Inhibitor Design for Monoamine Oxidases
Rona R. Ramsay
CURRENT PHARMACEUTICAL DESIGN (2013)
Monoamine Oxidases: The Biochemistry of the Proteins As Targets in Medicinal Chemistry and Drug Discovery
Rona R. Ramsay
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2013)
Antidepressant-like effect of trans-resveratrol in chronic stress model: Behavioral and neurochemical evidences
Yingcong Yu et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2013)
Opportunities for reversible inhibitors of monoamine oxidase-A (RIMAs) in the treatment of depression
Christopher T. Lum et al.
CNS SPECTRUMS (2012)
Patent-related survey on new monoamine oxidase inhibitors and their therapeutic potential
Simone Carradori et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2012)
Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives
Daniela Secci et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Flavonoids and the CNS
Anna K. Jager et al.
MOLECULES (2011)
Focusing on new monoamine oxidase inhibitors
Adriana Bolasco et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2010)
Synthesis, Molecular Modeling, and Selective Inhibitory Activity against Human Monoamine Oxidases of 3-Carboxamido-7-Substituted Coumarins
Franco Chimenti et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Structural and Mechanistic Studies of Mofegiline Inhibition of Recombinant Human Monoamine Oxidase B
Erika M. Milczek et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Structure of human monoamine oxidase A at 2.2-Å resolution:: The control of opening the entry for substrates/inhibitors
Se-Young Son et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Aggregation of α-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine
William J. Burke et al.
ACTA NEUROPATHOLOGICA (2008)
Monoamine oxidase inhibition for tobacco pharmacotherapy
T. P. George et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Monoamine oxidase-B inhibition in the treatment of Parkinson's disease
Hubert H. Fernandez et al.
PHARMACOTHERAPY (2007)
Structural insights into monoamine oxidase inhibitory potency and selectivity of 7-substituted coumarins from ligand- and target-based approaches
Marco Catto et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of N,N′-bis[2-oxo-2H-benzopyran]-3-carboxamides
Franco Chimenti et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
The therapeutic potential of monoamine oxidase inhibitors
MBH Youdim et al.
NATURE REVIEWS NEUROSCIENCE (2006)
Binding of rasagiline-related inhibitors to human monoamine oxidases. a kinetic and crystallographic analysis
C Binda et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Recent development of monoamine oxidase inhibitors
A Bolasco et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2005)
Demonstration of isoleucine 199 as a structural determinant for the selective inhibition of human monoamine oxidase B by specific reversible inhibitors
F Hubálek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Monoamine oxidases A and B gene polymorphisms in migraine patients
V Filic et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
Crystal structures of monoamine oxidase B in complex with four inhibitors of the N-propargylaminoindan class
C Binda et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Structure and mechanism of monoamine oxidase
DE Edmondson et al.
CURRENT MEDICINAL CHEMISTRY (2004)
Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators
MD Berry
JOURNAL OF NEUROCHEMISTRY (2004)
Iron, brain ageing and neurodegenerative disorders
L Zecca et al.
NATURE REVIEWS NEUROSCIENCE (2004)
Age-dependent increase in hydrogen peroxide production by cardiac monoamine oxidase A in rats
A Maurel et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
Moclobemide: Therapeutic use and clinical studies
U Bonnet
CNS DRUG REVIEWS (2003)
Lazabemide, a selective, reversible monoamine oxidase B inhibitor, as an aid to smoking cessation
I Berlin et al.
ADDICTION (2002)
Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders
C Binda et al.
NATURE STRUCTURAL BIOLOGY (2002)
分享论文
